Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$62,854 Mln
Revenue (TTM)
$199,125 Mln
Net Profit (TTM)
$5,662 Mln
ROE
0.1 %
ROCE
7.5 %
P/E Ratio
11.3
P/B Ratio
1.5
Industry P/E
--
EV/EBITDA
0
Div. Yield
2.4 %
Debt to Equity
0.8
Book Value
$197.8
EPS
$25.5
Face value
--
Shares outstanding
220,704,667
CFO
$60,274.60 Mln
EBITDA
$62,196.40 Mln
Net Profit
$42,610.30 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Elevance Health Inc (ELV)
| -14.9 | -6.8 | -14.9 | -31.0 | -13.4 | -3.3 | 7.7 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P 100
| -7.4 | -4.4 | -6.8 | 17.6 | 19.5 | 11.9 | 13.3 |
|
Company
|
2025
|
2024
|
2023
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Elevance Health Inc (ELV)
| -5.0 | -21.6 | -8.1 | 46.1 | 7.7 | 16.3 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Elevance Health Inc (ELV)
|
298.4 | 62,854.5 | 199,125.0 | 5,662.0 | 4.1 | 13.3 | 11.3 | 1.5 |
| 18.7 | 3,442.4 | 3,948.7 | -0.7 | 0.4 | -0.5 | -- | 19.8 | |
| 34.9 | 15,638.4 | 194,777.0 | -6,673.0 | -3.3 | -28.8 | -- | 0.8 | |
| 269.0 | 68,939.8 | 274,952.0 | 5,957.0 | 3.4 | 14.4 | 11.6 | 1.7 | |
| 1.8 | 902.4 | 1,924.3 | -85.6 | -4.4 | -26.3 | -- | 3.2 | |
| 22.4 | 12,800.6 | 19,628.0 | 978.0 | 9.1 | 6.8 | 11.4 | 0.8 | |
| 176.4 | 20,018.9 | 129,664.0 | 1,188.0 | 1.6 | 7 | 16.9 | 1.2 | |
| 137.9 | 6,848.4 | 45,426.0 | 472.0 | 1.7 | 11 | 14.8 | 1.8 | |
| 16.5 | 1,389.9 | 1,288.7 | 58.5 | 7.2 | 12.5 | 26.1 | 2.9 | |
| 275.2 | 237,620.5 | 447,567.0 | 12,056.0 | 4.2 | 12.9 | 19.8 | 2.5 |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of... health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana. Address: 220 Virginia Avenue, Indianapolis, IN, United States, 46204 Read more
President, CEO & Director
Ms. Gail Koziara Boudreaux
President, CEO & Director
Ms. Gail Koziara Boudreaux
Headquarters
Indianapolis, IN
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Elevance Health Inc (ELV) is $298.38 (NYSE) as of 02-Apr-2026 14:45 EDT. Elevance Health Inc (ELV) has given a return of -13.42% in the last 3 years.
The P/E ratio of Elevance Health Inc (ELV) is 11.30 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.73
|
1.77
|
|
2024
|
14.26
|
2.06
|
|
2023
|
18.57
|
2.83
|
|
2022
|
20.99
|
3.41
|
|
2021
|
18.64
|
3.15
|
The 52-week high and low of Elevance Health Inc (ELV) are Rs 458.75 and Rs 273.71 as of 03-Apr-2026.
Elevance Health Inc (ELV) has a market capitalisation of $ 62,854 Mln as on 31-Mar-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Elevance Health Inc (ELV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.12
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.